Background

A pharmaceutical manufacturer faced a significant capacity shortfall for a high-value drug product, with demand forecasts projecting accelerated growth. The expansion carried a high-risk profile due to complex interdependencies across construction, utilities, automation, commissioning and qualification (CQV), quality approvals, and regulatory submissions.

Compounding the challenge was an aggressive 24-month delivery timeline, alongside global supply chain volatility impacting critical equipment such as lyophilizers and isolators. Any delay across these integrated workstreams could jeopardize commercial supply continuity and regulatory readiness.

To mitigate risk and ensure timely delivery, the organization engaged Regulatory Compliance Associates® (RCA).

RCA Approach

RCA appointed a dedicated Program Manager (PM) to lead the initiative and assume ownership of the Integrated Master Plan (IMP) and Integrated Master Schedule (IMS). The PM coordinated all functional areas to ensure alignment across the project lifecycle, including:

• Construction and facility build-out
• Commissioning & Qualification (CQV)
• Quality and QA oversight
• Regulatory strategy and submission readiness
• Compliance activities (CSV/GxP)
• Environmental Health & Safety (EHS)
• Operations readiness

A phase-gated governance model was established to control risk, enforce accountability, and align technical milestones with regulatory deliverables. RCA integrated CQV activities directly with validation planning and regulatory timelines to prevent downstream delays.

Inspection readiness was embedded early in the project, with proactive quality oversight and compliance alignment to ensure a seamless transition from build completion to regulatory approval.

Results

• The facility was delivered, commissioned, and validated in Month 23, ahead of the 24-month target.
• All critical utilities passed qualification on the first attempt.
• The FDA inspection resulted in zero Form 483 observations.
• The facility was cleared for commercial manufacturing within eight weeks of inspection.

Through disciplined program management, integrated governance, and proactive regulatory alignment, RCA helped the client successfully expand capacity while minimizing operational and compliance risk.